Trump Administration Secures 500,000 Courses Of Covid Drug Remdesivir

The Washington Post (6/29, Denham) reports that on Monday, Gilead Sciences, the maker of remdesivir, “the first covid-19 treatment found to have worked in clinical trials...said...it will charge U.S. hospitals $3,120 for the typical patient with private i...